TherapeuticsMD, Inc. — Director's Dealing 2004

Jun 30, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (coff)
CIK: 0000025743
Period of Report: 2004-06-22

Reporting Person: JENSEN GERALD L (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-06-22	Common Stock	P	2500	$0.84	Acquired	233714	Direct
2004-06-22	Common stock	P	1500	$1.07	Acquired	235214	Direct
2004-06-28	Common stock	P	3900	$0.84	Acquired	239114	Direct
2004-06-29	Common Stock	P	1774	$1.1	Acquired	240888	Direct
2004-06-29	Common Stock	P	500	$1.29	Acquired	241388	Direct